DaVita Revenue 2010-2024 | DVA

DaVita annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • DaVita revenue for the quarter ending March 31, 2024 was $3.071B, a 6.89% increase year-over-year.
  • DaVita revenue for the twelve months ending March 31, 2024 was $12.338B, a 5.77% increase year-over-year.
  • DaVita annual revenue for 2023 was $12.14B, a 4.57% increase from 2022.
  • DaVita annual revenue for 2022 was $11.61B, a 0.08% decline from 2021.
  • DaVita annual revenue for 2021 was $11.619B, a 0.59% increase from 2020.
DaVita Annual Revenue
(Millions of US $)
2023 $12,140
2022 $11,610
2021 $11,619
2020 $11,551
2019 $11,388
2018 $11,405
2017 $10,877
2016 $10,707
2015 $9,982
2014 $12,795
2013 $11,764
2012 $8,186
2011 $6,732
2010 $6,220
2009 $6,101
DaVita Quarterly Revenue
(Millions of US $)
2024-03-31 $3,071
2023-12-31 $3,146
2023-09-30 $3,121
2023-06-30 $3,000
2023-03-31 $2,873
2022-12-31 $2,917
2022-09-30 $2,949
2022-06-30 $2,927
2022-03-31 $2,818
2021-12-31 $2,944
2021-09-30 $2,938
2021-06-30 $2,917
2021-03-31 $2,820
2020-12-31 $2,905
2020-09-30 $2,924
2020-06-30 $2,880
2020-03-31 $2,841
2019-12-31 $2,899
2019-09-30 $2,904
2019-06-30 $2,843
2019-03-31 $2,743
2018-12-31 $2,821
2018-09-30 $2,847
2018-06-30 $2,887
2018-03-31 $2,849
2017-12-31 $2,781
2017-09-30 $2,765
2017-06-30 $2,699
2017-03-31 $2,631
2016-12-31 $-322
2016-09-30 $3,731
2016-06-30 $3,718
2016-03-31 $3,581
2015-12-31 $-266
2015-09-30 $3,526
2015-06-30 $3,435
2015-03-31 $3,288
2014-12-31 $3,328
2014-09-30 $3,252
2014-06-30 $3,172
2014-03-31 $3,043
2013-12-31 $3,063
2013-09-30 $3,000
2013-06-30 $2,872
2013-03-31 $2,830
2012-12-31 $2,478
2012-09-30 $1,946
2012-06-30 $1,913
2012-03-31 $1,850
2011-12-31 $1,750
2011-09-30 $1,758
2011-06-30 $1,661
2011-03-31 $1,562
2010-12-31 $1,424
2010-09-30 $1,650
2010-06-30 $1,587
2010-03-31 $1,559
2009-12-31 $1,560
2009-09-30 $1,574
2009-06-30 $1,519
2009-03-31 $1,448
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.299B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.002B 10.28
Quest Diagnostics (DGX) United States $15.353B 15.87
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Chemed (CHE) United States $8.076B 25.03
Option Care Health (OPCH) United States $4.839B 18.32
RadNet (RDNT) United States $4.232B 88.12
Amedisys (AMED) United States $2.993B 21.20
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00